breast cancerresistancemetforminexosomesintercellular interactionsproteomeрак молочной железырезистентностьметформинэкзосомымежклеточное взаимодействиепротеом1.1. Evans J.M., Donnelly L.A., Emslie- Smith A.M. et al. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005;330(7503):1304–5.Evans J.M., Donnelly L.A., Emslie- Smith A.M. et al. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005;330(7503):1304–5.2.2. Shcherbakov A.M., Andreeva O.E., Shatskaya V.A., Krasil’nikov M.A. The relationships between snail1 and estrogen receptor signaling in breast cancer cells. J Cell Biochem 2012;113(6):2147–55.Shcherbakov A.M., Andreeva O.E., Shatskaya V.A., Krasil’nikov M.A. The relationships between snail1 and estrogen receptor signaling in breast cancer cells. J Cell Biochem 2012;113(6):2147–55.3.3. Viedma-Rodriguez R., Baiza-Gutman L., Salamanca-Gómez F. et al. Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review). Oncol Rep 2014;32(1):3–15.Viedma-Rodriguez R., Baiza-Gutman L., Salamanca-Gómez F. et al. Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review). Oncol Rep 2014;32(1):3–15.4.4. Nalvarte I., Schwend T., Gustafsson J.A. Proteomics analysis of the estrogen receptor alpha receptosome. Mol Cell Proteomics 2010;9(7):1411–22.Nalvarte I., Schwend T., Gustafsson J.A. Proteomics analysis of the estrogen receptor alpha receptosome. Mol Cell Proteomics 2010;9(7):1411–22.5.5. Bihani T., Ezell S.A., Ladd B. et al. Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers. Oncotarget 2015;6(4):2407–20.Bihani T., Ezell S.A., Ladd B. et al. Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers. Oncotarget 2015;6(4):2407–20.6.6. Oliveras-Ferraros C., Vazquez-Martin A., Cuyàs E. et al. Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile. Cell Cycle 2014;13(7):1132–44.Oliveras-Ferraros C., Vazquez-Martin A., Cuyàs E. et al. Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile. Cell Cycle 2014;13(7):1132–44.7.7. Shcherbakov A.M., Sorokin D.V., Tatar- skiy V.V. Jr et al. The phenomenon of acquired resistance to metformin in breast cancer cells: the interaction of growth pathways and estrogen receptor signaling. IUBMB Life 2016;68(4):281–92.Shcherbakov A.M., Sorokin D.V., Tatar- skiy V.V. Jr et al. The phenomenon of acquired resistance to metformin in breast cancer cells: the interaction of growth pathways and estrogen receptor signaling. IUBMB Life 2016;68(4):281–92.8.8. Семина С.Е., Багров Д.В., Красильников М.А. Межклеточные взаимодействия и развитие гормональной резистентности клеток рака молочной железы. Успехи молекулярной онкологии 2015;2(2):50–5. [Semina S.E., Bagrov D.V., Krasil’nikov M.A. Intercellular interactions and progression of hormonal resistance of breast cancer cells. Uspekhi molekulyarnoy onkologii = Advances in Molecular Oncology 2015;2(2):50–5. (In Russ.)].Семина С.Е., Багров Д.В., Красильников М.А. Межклеточные взаимодействия и развитие гормональной резистентности клеток рака молочной железы. Успехи молекулярной онкологии 2015;2(2):50–5. [Semina S.E., Bagrov D.V., Krasil’nikov M.A. Intercellular interactions and progression of hormonal resistance of breast cancer cells. Uspekhi molekulyarnoy onkologii = Advances in Molecular Oncology 2015;2(2):50–5. (In Russ.)].9.9. Reid G., Hübner M.R., Métivier R. et al. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 2003;11(3):695–707.Reid G., Hübner M.R., Métivier R. et al. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 2003;11(3):695–707.10.10. Thery C., Amigorena S., Raposo G., Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006. Chapter 3: Unit 3.22.Thery C., Amigorena S., Raposo G., Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006. Chapter 3: Unit 3.22.11.11. Yang B., Wang S., Yu S. et al. C1q/tumor necrosis factor-related protein 3 inhibits oxidative stress during intracerebral hemorrhage via PKA signaling. Brain Res 2017;1657:176–84.Yang B., Wang S., Yu S. et al. C1q/tumor necrosis factor-related protein 3 inhibits oxidative stress during intracerebral hemorrhage via PKA signaling. Brain Res 2017;1657:176–84.12.12. Choi J., Kim D.I., Kim J. et al. Hornerin is involved in breast cancer progression. J Breast Cancer 2016;19(2): 142–7.Choi J., Kim D.I., Kim J. et al. Hornerin is involved in breast cancer progression. J Breast Cancer 2016;19(2): 142–7.13.13. Wang Z.C., E D., Batu D.L. et al. 2DDIGE proteomic analysis of changes in estrogen/progesterone-induced rat breast hyperplasia upon treatment with the Mongolian remedy RuXian-I. Molecules 2011;16(4):3048–65.Wang Z.C., E D., Batu D.L. et al. 2DDIGE proteomic analysis of changes in estrogen/progesterone-induced rat breast hyperplasia upon treatment with the Mongolian remedy RuXian-I. Molecules 2011;16(4):3048–65.14.14. Queiroz E.A., Puukila S., Eichler R. et al. Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells. PLoS One 2014;9(5): e98207Queiroz E.A., Puukila S., Eichler R. et al. Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells. PLoS One 2014;9(5): e98207